(OE) Prot# 283PD201: A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson's Disease

Project: Research project

Project Details

StatusActive
Effective start/end date1/3/23 → 1/3/26

Funding

  • Quintiles, Inc. (Prot# 283PD201 // Prot# 283PD201)
  • Biogen MA Inc. (Prot# 283PD201 // Prot# 283PD201)